Prognostic Impact of Aortic Calcification Index and Ankle-Arm Blood Pressure Indexin Patients under Hemodialysis

Author:

Kushiya Fumihiko1,Wada Hideo2,Sakakura Miho1,Mori Yoshitaka3,Gabazza Esteban C.4,Nishikawa Masakatsu1,Nobori Tsutomu2,Noguchi Mitsuya5,Izumi Kazuo5,Nakasaki Takahiro6,Takagi Mikio7,Shiku Hiroshi1

Affiliation:

1. Second Department of Internal Medicine, Mie University School of Medicine

2. Department of Laboratory Medicine, Mie University School of Medicine

3. Mie Red Cross Center, Tsu-city

4. Third Department of Internal Medicine, Mie University School of Medicine

5. Department of Internal Medicine,Matsusaka Chuou Hospital, Matsusaka-city

6. Department of Internal Medicine, Tooyama Hospital, Tsu-city

7. Department of Internal Medicine, Suzuka Chuou Hospital, Suzuka-city, Mie-ken, Japan

Abstract

The mortality rate is high in patients receiving hemodialysis (HD), atherosclerotic diseases being the major cause of death. As marker of clinical outcome, a prospective examination of atherosclerotic tests and atherosclerotic risk factors in patients receiving HD was performed. On April 2000, 84 patients receiving HD were followed up until April 2002. At entry to the study, several atherosclerotic tests, including ankle-arm blood pressure index (API), aortic calcification index (ACI), and atherosclerotic risk factors, were performed. In 36 patients with old thrombotic events, 26 had new thrombotic events. Of 48 patients without previous thrombotic events, 15 had new thrombotic events. During 2 years, 41 patients had new thrombotic events and 15 patients died due to thrombotic disorders. The HD durations were significantly longer in non-survivors than survivors and the body mass index was lower in non-survivors than survivors. There was a significant difference in the values of ACI and API between survivors and non-survivors, and between patients with and without thrombotic events. These findings suggest that the ACI and API have a prognostic value because they might predict the occurrence of thrombosis.

Publisher

SAGE Publications

Subject

Hematology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3